established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be
shares Company’s name Aesthetic Zecret (At-Ze) Co., Ltd. Business type At-Ze established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and
derivatives business operator shall submit an application for approval to the Office of the Securities and Exchange Commission together with supplementary documents in accordance with the form and procedure
operator shall submit an application for approval to the Office of the Securities and Exchange Commission together with supplementary documents in accordance with the form and procedure provided in the SEC’s
to be director or manager, the derivatives business operator shall submit an application for approval to the Office of the Securities and Exchange Commission together with supplementary documents in
1,122.74 1,024.78 97.95 9.56% Shareholders’ equity Issued and paid-up 400.00 400.00 - 0.00% Premium on paid-up capital 305.53 305.53 - 0.00% Share surplus from business combination under common control 20.64
2018 2017 Items that will be reclassified subsequently to profit or loss: Surplus on land revaluation – net of tax 66,240 - 100% - - Items that will not be reclassified subsequently to profit or loss
’ equity Issued and paid-up 400.00 400.00 - 0.00% Premium on paid-up capital 305.53 305.53 - 0.00% Share surplus from business combination under common control 20.64 20.64 - 0.00% Retained earnings 78.02
management will consider using the surplus CFO in investment or any other activities to create better value for the Company. Cash Flow from Investing Activities CFI as of June 30, 2020 was -48.45mb mainly due
be reclassified subsequently to profit or loss: Surplus on land revaluation – net of tax - 66,240 -100% - - Items that will not be reclassified subsequently to profit or loss: Actuarial gains (loss